02 March 2026
No Right Adjustment of BC-W4
02 March 2026
Resolutions of the BOD Meeting No. 1/2026 regarding the omission of dividend payment, capital reduction, capital increase, issuance of ESOP shares, allocation of RO-warrants, and the schedule of 2026 AGM (Revised Enclosure 2)
27 February 2026
Resolutions of the BOD Meeting No. 1/2026 regarding the omission of dividend payment, capital reduction, capital increase, issuance of ESOP shares, allocation of RO-warrants, and the schedule of 2026 Annual General Meeting of Shareholders
27 February 2026
Management Discussion and Analysis Yearly Ending 31 Dec 2025
27 February 2026
Financial Performance Yearly (F45) (Audited)
27 February 2026
Financial Statement Yearly 2025 (Audited)
11 February 2026
Notification of the exercise of BC-W4 (No. 3)
06 February 2026
New shares of BC to be traded on February 9, 2026
03 February 2026
Report on the results of sale of common shares offered to employee stock option program (F53-5)
30 January 2026
03 February 2026 is the last trading day of BC-W3
16 January 2026
Report on the utilization of proceeds from capital increase for the period ended 31 December 2025
14 January 2026
New shares of BC to be traded on January 15, 2026